Neuroglobin As Key Mediator in the 17β-Estradiol-Induced Antioxidant Cell Response to Oxidative Stress
- 2 January 2020
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 32 (4) , 217-227
Abstract
Aims: Nuclear factor (erythroid-derived 2)-like-2 factor (NRF-2) is a transcription factor well known to provide an advantage for cancer growth and survival regulating the cellular redox pathway. In breast cancer cells, we recently identified the monomeric heme-globin neuroglobin (NGB) as part of a new mechanism induced by the steroid hormone 17β-estradiol (E2) against oxidative stress. While there is mounting evidence suggesting a critical role of NGB as a sensor of oxidative stress, scarce information is available about its involvement in NRF-2 pathway activation in breast cancer cells. Results: Although NGB is not involved in the rapid E2-induced NRF-2 stability, E2 loses the capacity to regulate the expression of NRF-2-dependent genes in NGB-depleted MCF-7 cells. These data strongly sustain a role of NGB as a compensatory protein in the E2-activated intracellular pathway devoted to the increase of cancer cells tolerance to reactive oxygen species (ROS) generation in stressing conditions acting as key regulator of NRF-2 pathway activity in a time-dependent manner. Innovation: In this study, we identified a new role of NGB in the cell response to oxidative stress. Conclusion: Altogether, reported results open new insights on the NGB effect in regulating intracellular pathways related to cell adaptive response to stress and, as consequence, to cell survival, beyond its direct effect as ROS scavenger, opening new prospective in cancer therapeutic intervention.Keywords
This publication has 51 references indexed in Scilit:
- Neuroglobin: From structure to function in health and diseaseMolecular Aspects of Medicine, 2016
- Nrf2-Keap1 Antioxidant Defense and Cell Survival Signaling Are Upregulated by 17β-Estradiol in Homocysteine-Treated Dopaminergic SH-SY5Y CellsNeuroendocrinology, 2012
- Crosstalk between Nrf2 and the proteasome: Therapeutic potential of Nrf2 inducers in vascular disease and agingThe International Journal of Biochemistry & Cell Biology, 2012
- The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma MembraneFrontiers in Physiology, 2011
- What is the function of neuroglobin?Journal of Experimental Biology, 2009
- Repression of cancer protective genes by 17β-estradiol: Ligand-dependent interaction between human Nrf2 and estrogen receptor αMolecular and Cellular Endocrinology, 2005
- 17β‐oestradiol up‐regulates longevity‐related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFκB cascadeAging Cell, 2005
- Palmitoylation-dependent Estrogen Receptor α Membrane Localization: Regulation by 17β-EstradiolMolecular Biology of the Cell, 2005
- Estrogen and the Risk of Breast CancerNew England Journal of Medicine, 2001
- Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7.Proceedings of the National Academy of Sciences, 1984